title: Global Advisory Committee on Vaccine Safety, December 2012.
mesh_terms: D019433:Chickenpox Vaccine / Q000009:adverse effects / Q000627:therapeutic use; D053059:Dengue Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D014943:Global Health; D020275:Guillain-Barre Syndrome / Q000209:etiology; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000009:adverse effects / Q000627:therapeutic use; D009290:Narcolepsy / Q000209:etiology; D012449:Safety; D014612:Vaccines / Q000009:adverse effects* / Q000627:therapeutic use*; D014613:Vaccines, Attenuated / Q000009:adverse effects / Q000627:therapeutic use; D014944:World Health Organization
chemical_list: D019433:Chickenpox Vaccine; D053059:Dengue Vaccines; D007252:Influenza Vaccines; D014612:Vaccines; D014613:Vaccines, Attenuated; C556153:pandemrix